Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Biomed Research International|October 1, 2016
Key Challenges and Opportunities Associated with the Use of In Vitro Models to Detect Human DILI: Integrated Risk Assessment and Mitigation PlansFranck A Atienzar, Eric A Blomme, Minjun Chen, et al.The Journal of Pharmacology and Experimental Therapeutics|June 7, 2014
Mass spectrometric characterization of circulating covalent protein adducts derived from a drug acyl glucuronide metabolite: multiple albumin adductions in diclofenac patientsThomas G Hammond, Xiaoli Meng, Rosalind E Jenkins, et al.ALTEX|January 24, 2023
Incorporating new approach methodologies into regulatory nonclinical pharmaceutical safety assessmentJan Turner, Pandora Pound, Carla Owen, et al.Drug Discovery Today|November 24, 2018
Advancing nonclinical innovation and safety in pharmaceutical testingElizabeth J Baker, Nancy A Beck, Ellen L Berg, et al.ALTEX|November 1, 2024
Corrigendum to Incorporating new approach methodologies into regulatory nonclinical pharmaceutical safety assessmentJan Turner, Pandora Pound, Carla Owen, et al.Clinical Pharmacology and Therapeutics|August 24, 2018
Can Bile Salt Export Pump Inhibition Testing in Drug Discovery and Development Reduce Liver Injury Risk? An International Transporter Consortium PerspectiveJ Gerry Kenna, Kunal S Taskar, Christina Battista, et al.Nature Reviews. Drug Discovery|April 2, 2011
Managing the challenge of chemically reactive metabolites in drug developmentB Kevin Park, Alan Boobis, Stephen Clarke, et al.Pageof 4